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Abstract
Objective To determine the relative accuracy of clinic measurements
and home blood pressure monitoring compared with ambulatory blood
pressure monitoring as a reference standard for the diagnosis of
hypertension.
Design Systematic review with meta-analysis with hierarchical summary
receiver operating characteristic models. Methodological quality was
appraised, including evidence of validation of blood pressure
measurement equipment.
Data sources Medline (from 1966), Embase (from 1980), Cochrane
Database of Systematic Reviews, DARE, Medion, ARIF, and TRIP up
to May 2010.
Eligibility criteria for selecting studies Eligible studies examined
diagnosis of hypertension in adults of all ages using home and/or clinic
blood pressure measurement compared with those made using
ambulatory monitoring that clearly defined thresholds to diagnose
hypertension.
Results The 20 eligible studies used various thresholds for the diagnosis
of hypertension, and only seven studies (clinic) and three studies (home)
could be directly compared with ambulatory monitoring. Compared with
ambulatory monitoring thresholds of 135/85 mm Hg, clinic measurements
over 140/90 mm Hg had mean sensitivity and specificity of 74.6% (95%
confidence interval 60.7% to 84.8%) and 74.6% (47.9% to 90.4%),
respectively, whereas home measurements over 135/85 mm Hg had
mean sensitivity and specificity of 85.7% (78.0% to 91.0%) and 62.4%
(48.0% to 75.0%).
Conclusions Neither clinic nor home measurement had sufficient
sensitivity or specificity to be recommended as a single diagnostic test.
If ambulatory monitoring is taken as the reference standard, then
treatment decisions based on clinic or home blood pressure alone might
result in substantial overdiagnosis. Ambulatory monitoring before the
start of lifelong drug treatment might lead to more appropriate targeting
of treatment, particularly around the diagnostic threshold.
Introduction
High blood pressure is a key risk factor for the development of
cardiovascular disease
1 and is a major cause of morbidity and
mortality worldwide.
2 Hypertension is the commonest chronic
disorder seen in primary care, with around one in eight of all
people receiving antihypertensive treatment.
3 4
Initial management of hypertension conventionally requires a
diagnosis based on several clinic or office blood pressure
measurements.
5-7 National and international guidelines
recommend similar strategies, although the thresholds of blood
pressure for diagnosis and risk vary.
5-9 Ambulatory blood
pressure monitoring, however, estimates “true” mean blood
pressure more accurately than clinic measurement because
multiplereadingsaretaken;ithasalsobeenshowntohavebetter
correlation with a range of cardiovascular outcomes and end
organ damage.
10-15 Ambulatory blood pressure monitoring is
typicallyusedwhenthereisuncertaintyindiagnosis,resistance
to treatment, irregular or diurnal variation, or concerns about
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RESEARCHvariability and the “white coat” effect.
16 17 18 It has therefore
arguably become the reference standard for the diagnosis of
hypertension.
Home blood pressure monitoring, which provides multiple
readings over several days, is also better correlated with end
organ damage than clinic measurement.
19 20 It seems to be a
better prognostic indicator with respect to stroke and
cardiovascular mortality
21-23 and can identify white coat and
maskedhypertension.Itcouldprovideanappropriatealternative
to ambulatory monitoring in terms of diagnosis, particularly in
primary care where it might not be immediately available or
deemed too costly or when patients find it inconvenient or
uncomfortable. Home monitoring has a smaller evidence base
than ambulatory monitoring but has gained acceptance over
recentyearsasdataaccumulateandaccurateequipmentbecomes
more widely available.
24 25
If guidelines are to retain clinic measurement as a standard
diagnostic tool, it is important to assess these in the light of
ambulatory measurement. Similarly, for home measurements
to be considered as an alternative to ambulatory measurements
thentheirtestperformanceneedstobeevaluated.Weconducted
a systematic review of the test performance of the diagnosis of
hypertension by clinic measurement and home monitoring
comparedwiththereferencestandardofambulatorymonitoring.
Methods
Inclusion criteria
We had various criteria for inclusion.
Types of study—Studies had to have extractable data for
diagnoses of hypertension made with home and/or clinic blood
pressure measurement compared with those made with
ambulatorymeasurement.Therewasnorestrictiononlanguage
or year of publication.
Types of participants in studies—We included adult patients of
all ages. Studies were excluded if participants were pregnant,
inhospital,orreceivingtreatmentatthetimeofthecomparison,
unless these groups could be excluded from other data within
a paper. Although we aimed to derive data relevant to primary
care, no restriction was placed on setting other than excluding
patients in hospital.
Typesofoutcomemeasures—Weextracteddatainto2×2tables
for comparisons of the diagnosis of hypertension provided that
clearly defined thresholds for the diagnosis of hypertension
were used. Studies from which 2×2 tables could not be derived
were excluded.
Reference standard—We chose ambulatory monitoring as the
reference standard, with 135/85 mm Hg as the internationally
accepted threshold for diagnosis on mean daytime readings.
7
Among the various indirect methods of measuring blood
pressure, ambulatory monitoring shows the strongest relation
with clinical outcome and estimates blood pressure more
accurately because multiple readings are taken.
10-15 It thus
represents the most appropriate choice of reference standard.
Some studies have suggested that night time average blood
pressure is superior to daytime at predicting cardiovascular
outcomes,
26 but there is greater consensus over the threshold to
use for daytime averages than night time averages.
5 7
Search strategy
WesearchedMedline(from1950onwards),Embase(from1980
onwards), the Cochrane Database of Systematic Reviews,
DARE, Medion (www.mediondatabase.nl), ARIF (www.arif.
bham.ac.uk), and the TRIP database (www.tripdatabase.com)
up to May 2010, using a search strategy designed to capture all
studies evaluating the test performance characteristics of
different methods of diagnosing hypertension in primary care.
Thesearchstrategywasbasedonthediagnosticfiltersdeveloped
by Haynes et al
27 and Montori et al.
28 To improve sensitivity in
the search,
29 however, we combined three separate search
strategies using Medline and Embase (the full Medline search
strategy is shown in appendix 2 on bmj.com): we combined
keywords for hypertension, blood pressure monitoring,
outpatient setting, and diagnosis; we limited MeSH terms for
hypertension to diagnosis subheading and combined this with
keywords for blood pressure monitoring and outpatient setting;
and we combined keywords for hypertension, blood pressure
monitoring, outpatient setting, and limit using the diagnosis
search filter.
Selection of studies
Two reviewers (JH and RJMcM) independently reviewed the
titles and abstracts of articles identified by the search strategy
for potential relevance to the research question. After this
process, the full papers of potentially eligible papers were
assessed.
Data management and extraction
Two of four reviewers (JH, RJMcM, UM, JM) carried out data
extractionfromincludedpapersinduplicate(thedataextraction
formtemplateisinappendix3onbmj.com).Differencesindata
extraction were resolved by consensus. When necessary we
contactedtheauthorsoftheprimarystudiestoobtainadditional
information.
Assessment of methodological quality
We additionally collected information on recognised sources
of bias in diagnostic test accuracy studies using a version of the
QUADAS(QualityAssessmentofDiagnosticAccuracyStudies)
checklist,
30 adapted for this study. The box lists the quality
criteria considered.
Data synthesis
We extracted estimates of sensitivity and specificity from each
study for all reported threshold combinations of clinic or home
measurement and ambulatory measurement. We identified the
subset of studies where the combined data shared the common
reference threshold (ambulatory office monitoring 135/85 mm
Hg)andcarriedoutameta-analysisusinghierarchicalsummary
receiver operating characteristic (HSROC) models that
accounted for sampling variability, unexplained heterogeneity,
and covariation between sensitivity and specificity.
29 Models
were fitted to estimate and compare the sensitivity and
specificity for diagnosis of hypertension made at the most
common thresholds (140/90 mm Hg for clinic measurement,
135/85 mm Hg for home measurement). Differences between
thetestswereexpressedasrelativesensitivitiesandspecificities
to ascertain if there was a significant difference in the relative
performance of the tests compared with ambulatory
measurement. In a final analysis all studies were included to
explore the effect of different diagnostic thresholds. Models
were fitted with the SAS Metadas code
31 32 and graphics
producedwithRevMan5.
33Whentherewerenotenoughstudies
available for fitting, we simplified the full models by assuming
a symmetric receiver operating characteristic curve and fitting
a fixed rather than random effects model. Sensitivity analyses
considered the effect of differing the diagnostic thresholds, as
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RESEARCHQuality criteria
• Selection criteria of participants: both the inclusion criteria and how participants were selected (consecutively, randomly,
or other clear justifiable process) should be described
• Time period between the different methods of measurements: four weeks or less between any measurements
compared
• Blinding of those performing tests to previous measurements
• Reporting of uninterpretable results: reporting where recording was incomplete
• Reference standard: the whole sample had to receive the same comparison measurement tests, regardless of the
results of the index test result
• Attrition: information provided on any loss of subjects during the study
• Adequate checking of self monitored readings
• Equipment validation: evidence that all measurement equipment was clinically validated
well as assessing test performance in populations with mean
clinic blood pressure at or above the diagnostic threshold, to
separatelyconsiderwherestudypopulationshadbeenrecruited
entirely from a typical screening population (and so excluding
any studies where an additional group of normotensive people
were included as “controls”). Further analyses were planned
with other population characteristics, methodological quality
of the studies, and methods of monitoring.
Results
Our search identified 2914 studies (excluding duplicates), and
we reviewed the full text of 115 papers for eligibility (fig 1).
Of these, 20 contained extractable data; three were not written
in English (one each in French, Spanish, and Dutch). The 20
studies included 5863 individuals with mean age of 48.8 and
mean proportion of women of 57%.
Table 1 gives details of the population of each study
34-53 and
table2givesdetailsoftheirmethodologicalquality.Thestudies
differed markedly in terms of age (mean age ranged from <33
to 60), sex (percentage of men ranged from 16% to 69%),
sample size (from 16 to 2370), and whether a primary care or
specialist population was used. All the studies had some degree
of methodological weakness (or lack of clarity in what was
reported): only 11 out of 20 studies used validated devices for
all methods of monitoring, and only six provided evidence of
blinding of those conducting the monitoring to previous blood
pressureresults.Allstudiesavoidedbothpartialanddifferential
verification bias (that is, all patients in the studies received the
same comparison measurement tests, regardless of initial
results); reporting of attrition and selection criteria of
participants was good.
There was marked diversity between studies in terms of mean
baseline blood pressure of the population, number of
measurements for clinic (2-18), home (18-56), and ambulatory
monitoring (24-111), period of ambulatory measurement, and
bloodpressurethresholdsused(tables3and4).Similardiversity
was seen in the range of sensitivity and specificity values for
individual studies (tables 5 and 6). Two studies reported very
low specificities: Denolle
37 (specificity 0%) and Elijovich et al
38
(18%), both of which had small sample sizes. The study by
Denolle included a total sample of 16 patients, and none was
normotensive according to both clinic and ambulatory
classifications.InElijovichetal,onlythreeoutofatotalsample
of 72 patients were normotensive according to both clinic and
ambulatory classifications.
38
We pooled studies with the same thresholds for the reference
and index tests and included them in a meta-analysis. Eight
studiesusedathresholdof135/85mmHgforambulatoryblood
pressuremonitoringand140/90mmHgforclinicbloodpressure
monitoringtodiagnosehypertension,
39 43 46 48-52whilethreeused
a threshold of 135/85 mm Hg for both ambulatory and home
diagnosis.
34 36 49Oneofthecliniccomparisonstudies,
39however,
used the mean of the full 24 hour ambulatory blood pressure
monitoring rather than mean of daytime readings and was
therefore not comparable with the others. Only one study
provided proportions diagnosed as hypertensive using all three
methodsofbloodpressuremonitoring.
49Figure2providesforest
plots of the sensitivity and specificity of eligible studies, with
performancewitheitherhomeorclinicmeasurementcompared
with ambulatory monitoring.
Figure 3 provides a summary receiver operating characteristic
plot for the seven clinic comparison studies (mean age 47.1;
mean proportion of women 57%). Most studies were within the
95%confidenceintervalofthesummarypoint,
46 48-50 52oratleast
close to the receiver operating characteristic curve,
51 showing
some consistency in results across the studies. The remaining
outlier study had a small sample size compared with the others,
had a younger age profile with a lower mean blood pressure,
and used an unvalidated monitor for clinic measurements.
39
Figure 4 plots the three home comparison studies (mean age
52.5; mean proportion of women 55%) on a summary receiver
operating characteristic plot. Despite having quite different
meanbloodpressuresandsettings,twoofthethreestudieswere
similar in terms of sensitivity and specificity.
36 49 With so few
studies in this group, however, we could not plot a confidence
interval or assess the statistical homogeneity.
A receiver operating characteristic (ROC) curve for a single
study shows the relation between the true positive rate
(sensitivity) and the false positive rate (100−specificity) for
different cut-off points. In a meta-analysis, the points represent
different studies, and the fitted summary ROC curves depict
trade-offs between sensitivity and specificity that arise because
ofdifferencesbetweenthestudies.Wherethestudiescombined
have different thresholds, the pattern might reflect variation
with threshold seen in a single study. Where the studies
combined share a threshold, the pattern will reflect trade-offs
caused by the other differences between the studies.
Table 7 shows the pooled sensitivity and specificity for home
blood pressure measurement and clinic blood pressure
measurement. Compared with ambulatory blood pressure
monitoring of 135/85 mm Hg, clinic measurement over 140/90
mm Hg had a mean sensitivity of 74.6% (95% confidence
interval 60.7% to 84.8%) and specificity of 74.6% (47.9% to
90.4%), whereas home measurement over 135/85 mm Hg had
a mean sensitivity of 85.7% (78.0% to 91.0%) and specificity
of62.4%(48.0%to75.0%).Neitherthedifferenceinsensitivity
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RESEARCH(relative sensitivity 1.15, 0.95 to 1.39) nor specificity (0.79,
0.40 to 1.55) between the home and clinic measurements was
significant.
Weexploredtrade-offsbetweensensitivityandspecificitywith
variation in blood pressure thresholds for home and clinic
measurements (table 8). Increases in specificity and decreases
in sensitivity with increasing threshold (and the converse for
decreasing threshold) were significant for performance home
measurements but not significant for the clinic measurements.
We could not carry out the planned sensitivity analyses
evaluating methodological quality, population characteristics,
ormonitoringmethodsbecauseofthesmallnumberofincluded
studies. The removal of the outlying study,
39 which used an
unvalidated monitor, resulted in marginal changes (because of
the small sample size of the excluded study) in sensitivity of
clinic measurement from 74.6% (60.7% to 84.8%) to 72.6%
(56.7% to 84.2%) and in specificity from 74.6% (47.9% to
90.4%) to 77.9% (49.1% to 92.8%).
Sensitivity analysis of clinic comparisons including only those
with mean blood pressures close to or above the diagnostic
threshold found a sensitivity of 85.6% (81.0% to 89.2%) and
specificityof45.9%(33.0%to59.3%)forclinicbloodpressure.
As all three included studies of home monitoring comparisons
used a typical general practice screening population with no
control group of normotensive people, we did not perform a
further sensitivity analysis.
Discussion
Summary of findings
This review has shown that neither clinic nor home
measurements of blood pressure are sufficiently specific or
sensitive in the diagnosis of hypertension. We included 20
studies with 5683 patients that compared different methods of
diagnosing hypertension in diverse populations with a range of
thresholds applied. In the nine studies that used similar
diagnostic thresholds and were included in the meta-analysis
(two comparing home with ambulatory measurement only, six
comparing clinic with ambulatory measurement only, and one
study comparing all three methods), neither clinic nor home
measurement could be unequivocally recommended as a single
diagnostic test. Clinic measurement, the current reference in
most clinical work and guidelines, performed poorly in
comparisonwithambulatorymeasurement,and,giventhatclinic
measurementsarealsoleastpredictiveintermsofcardiovascular
outcome, this is not reassuring for daily practice.
10-12 16-18 Home
monitoringprovidedbettersensitivityandmightbesuitablefor
ruling out hypertension given its relative ease of use and
availability compared with ambulatory monitoring. In the case
ofclinicmeasurement,theremovalofstudieswithameanblood
pressure in the normotensive range reduced specificity still
further. This has profound implications for the management of
hypertension,suggestingthatambulatorymonitoringmightlead
to more appropriate targeting of treatment rather than starting
patients on lifelong antihypertensive treatment on the basis of
clinic measurements alone, as currently recommended.
5 In
clinical practice, this will be particularly important near the
thresholdfordiagnosis,wheremosterrorsincategorisationwill
occur if ambulatory monitoring is not used.
Strengths and limitations of study
Weusedacomprehensivesearchstrategyinmultipledatabases
and all languages and are unlikely to have missed important
numbers of relevant papers. While we did apply quality
measures, we did not use a total measure of quality assessment
to limit included papers as it is recognised that combining
differentshortcomingscangeneratedistinctmagnitudesofbias,
even in opposing directions.
29 54
Themainweaknessofourstudyisthepaucityofdataavailable.
Only one study compared all three methods of measurement.
Because of a lack of consensus internationally, a plethora of
different thresholds was used, which meant that fewer than half
of the studies could be combined in the meta-analysis.
The planned sensitivity analyses based on methodological
quality, population characteristics, and monitoring schedule
could not be performed because of the small number of studies
andthemethodologicalweaknessesinherentinincludedstudies
thatwouldhavemadeinterpretationofsuchasubgroupanalysis
speculative.Thenumberofmeasurementsused,however,varied
between two and 18 for clinic measurements (though only one
study used more than six) compared with 18 to 42 for home
measurements. These differences will have contributed to the
observedheterogeneityandcouldexplainthepoorperformance
of clinic measurements, albeit that this is typical in clinical
practice. The mean age of the population in the clinic
comparison studies (47.1) was over five years younger than the
mean age in the home comparison studies (52.5) and younger
than a typical population of patients with hypertension in
primary care (mid-60s).
55
It was often not clear whether studies used validated
measurement equipment, and even when it was mentioned,
several studies provided validation citations on only some of
the sphygmomanometers used. Given the shortage of literature
on the subject, poor performance of a particular machine might
conceivably lead to biased overall conclusions. We included in
the meta-analysis only one study that used an unvalidated
monitor,
39 and exclusion of this study had a minimal effect on
the results.
The findings clearly depend on the choice of the reference
standard, and the three types of measurement are sufficiently
different such that whichever one of them is chosen as the
reference, the other two will perform relatively badly. The
comparability of the performance of home monitoring to clinic
measurement, rather than to ambulatory monitoring as might
have been expected, could also reflect a relative paucity of
relevantdata,astherewereonlythreehomecomparisonstudies,
with wide confidence intervals for specificity (48% to 75%),
with particularly poorly performance for home monitoring.
Ambulatory monitoring, while providing the best correlation
to outcome of the methods evaluated, nevertheless in general
represents a single 24 hour period in an individual’s life hence
itisimportantthata“normal”dayischosen,typicallyaworking
day. A study of the long term reproducibility of ambulatory
measurements taken three times over a two year period found
thatdaytimeambulatorybloodpressureprovidedareproducible
estimate in 54 people with borderline hypertension (correlation
coefficient 0.70 for systolic blood pressure).
56
Finally,wecannotconsidertheimplicationsforclinicalpractice
in terms of the best method of monitoring treatment effects as
our research question focused solely on diagnostic studies.
Comparisons with other studies
We could not find a previous study that combined literature on
the diagnosis of hypertension with different methods of
measurement. Guidelines to date have tended to recommend
the use of clinic measurement with ambulatory blood pressure
monitoringand,toalesserextent,homemonitoringassecondary
methods in special cases such as white coat hypertension.
5-9 24
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RESEARCHOur results suggest that while this is a pragmatic approach
supported by the results of treatment studies, more widespread
use of ambulatory blood pressure monitoring for the diagnosis
ofhypertension,particularlyaroundthethresholds,mightresult
in more appropriately targeted treatment.
Policy implications
The poor specificity of both clinic and home measurement and
poor sensitivity of clinic monitoring mean some people will be
treated who would be defined as normotensive on the basis of
ambulatory blood pressure monitoring. How big a proportion
this is of the total number of people labelled as hypertensive
willdependontheprevalenceofhypertensioninthepopulation
beingstudied.Thiscanbeseeninthesensitivityanalysiswhere
specificity drops as prevalence increases.
The positive and negative likelihood ratios were 2.07 and 0.25
forhomecomparedwithambulatorymeasurement(acrossthree
comparison studies), respectively, and 2.94 and 0.34 for clinic
compared with ambulatory measurement (across seven
comparison studies), respectively. This suggests some
correlation between the results of home or clinic measurement
and ambulatory monitoring, but the correlation is not strong
(positive likelihood ratios of over 10 and negative likelihood
ratios of less than 0.1 would indicate a strong relation
57). To
help interpret this for clinical practice,
58 if the prevalence of
hypertension was as low as 10% (for example, in people under
40),thenoutofeveryfourpositivediagnosesprovidedbyclinic
measurement, close to three would be incorrect as judged by
the reference standard of ambulatory measurement. If half of
the population were hypertensive (such as those over 65), this
wouldbereversed,andthreeoutofeveryfourpositivediagnoses
provided by clinic measurement would be correct with
ambulatory measurement. When prevalence is 50%, however,
it might be more accurate to use the results of the sensitivity
analysis where mean blood pressure in studies was close to or
abovethediagnosticthreshold,andhereonly61%ofdiagnoses
after clinic measurements would be correct (table 9).
Many people with a current diagnosis of hypertension might
not in fact have hypertension. This has important implications,
both for the effect of labelling itself on otherwise healthy
people
59-62 and for the cost effectiveness of treatment.
63 Perhaps
anapproachusingclinic(orhome)measurementsasascreening
testfollowedbyambulatorybloodpressuremonitoringforblood
pressures that are within 10 mm Hg of threshold might be
appropriatebeforedefinitivetreatmentbutarguablyawideruse
of ambulatory monitoring would be needed to avoid
overtreatment of white coat hypertension as well as detection
of masked cases.
Aswedidnothavesufficientstudiesthatusedahighthreshold,
we cannot determine the relevance of ambulatory monitoring
in people with high clinic readings. White coat hypertension,
however, can manifest with very high clinic readings,
64 and, in
the absence of a clinical indication for immediate treatment
(suchasthesignsandsymptomsofacceleratedhypertension
65),
clinicians might want to organise an urgent ambulatory
measurement rather than treat on the basis of limited clinic
measurements.
Conclusions
Ourstudysuggeststhatifambulatorybloodpressuremonitoring
is taken as the reference standard for the detection of
hypertension, then treatment decisions based on clinic or home
bloodpressurealone,usingthresholdsof140/90mmHg,result
insubstantialoverdiagnosis.Ambulatorymonitoringmightlead
to more appropriate targeting of treatment before the start of
lifelong drug treatment, particularly around the diagnostic
threshold. Considering the relative expense of ambulatory
monitoringequipment,costeffectivenessanalysesareessential
before wholesale changes to the diagnosis of hypertension can
be recommended.
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RESEARCHTables
Table 1| Population characteristics in individual studies of methods of measuring blood pressure compared with ambulatory monitoring
Study population§ % Men‡
Mean (SD if available)
age (years)† Sample size Comparison group* Study
Primary care at risk 41 58.4 181 Home Bayo 2006
34
Primary care at risk 52 47 94 Clinic Brueren 1995
35
Primary care 46 50.4 (11.0) 247 Home Den Hond 2003
36
Secondary care 69 45 (11) 16 Home/Clinic Denolle 1995
37
Secondary care 16 58.5 (1.6) 72 Clinic Elijovich 1992
38
Secondary care 57 32.7 47 Clinic Flores 2000
39
General population 62 45 66 Clinic Gourlay 1993
40
Secondary care 46 47.4 153 Clinic Hoegholm 1994
41
General population 31 56.3 (12.0) 684 Clinic Imai 1996
42
Community volunteers 52 45.1 (12.5) 65 Home/Clinic Larkin 1998
43
Primary care at risk 42 57.6 (12) 156 Home Llibre 2006
44
General population 62 38.7 (9.8) 139 Clinic Modesti 1994
45
General population/At risk 48 51.7 238 Clinic Ogedegbe 2008
46
Secondary care 52 45.0 (12.4) 126 Clinic Ozdemir 2000
47
General population/At risk 46 52.5 (14.6) 229 Clinic Shimbo 2009
48
Secondary care 55 48.4 (10.2) 133 Home/Clinic Stergiou 2000
49
Secondary care 61 48.5 (11.0) 288 Clinic Stergiou 2005
50§
General population 39 44 2370 Clinic Trudel 2009
51
Secondary care 49 60 (15) 388 Clinic Ungar 2004
52
Secondary care 33 48.0 171 Clinic Zabludowski 1992
53
*Stergiou
50 included self monitoring arm but was study of masked hypertension defined with clinic measurement so results of home monitoring usable only in
comparison with clinic monitoring arm and not in comparison with results of ambulatory measurements.
†In Flores
39 age 30.8 (7.9) in 20 normotensive people, 32.8 (7.2) in 20 with white coat hypertension, and 37.8 (7.8) in 7 with hypertension. In Hoegholm
41 age range
17-76, median 47; mean (SD) 48.0 (1.1) in those with ambulatory hypertension, 46.4 (1.8) in ambulatory normotensive people. In Ogedegbe
46 age 45.9 in
normotensive people, 56.3 in white coat hypertension, 56.0 in sustained hypertension, 52.2 in masked hypertension. In Zabludowski
53 age 48 in those with clinic
and ambulatory hypertension, 51 in clinic hypertension and ambulatory normotension, 47 in clinic normotension and ambulatory hypertension, 45 in clinic and
ambulatory normotension.
‡In Imai
42 percentage male is taken from whole sample, including treated and untreated patients.
§In Ogedegbe
46 sample drawn from physician referrals to hypertension centre in hospital and through media advertisements. In Shimbo
48 people with hypertension
recruited from hypertension centre in hospital and medical centre. Normotensive people recruited through advertisements. Trudel
51 included white collar workers
from three public insurance institutions.
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RESEARCHTable 2| Methodological quality* of included studies of methods of measuring blood pressure compared with ambulatory monitoring in
diagnosis of hypertension
Equipment
validation Checking Attrition
Reference
standard Reporting Blinding Replication
Measurement
times Selection Study
Y Y Y Y N Y Y N Y Bayo 2006
34
Y NA Y Y N Y Y N Y Brueren 1995
35
Y Y Y Y N N Y Y Y Den Hond 2003
36
N Y Y Y N N N Y Y Denolle 1995
37
N NA Y Y N N N Y N Elijovich 1992
38
N NA Y Y N N N N Y Flores 2000
39
N NA Y Y N Y Y N Y Gourlay 1993
40
N NA N Y N N Y Y Y Hoegholm 1994
41
N NA Y Y N N N N Y Imai 1996
42
N N Y Y N N Y Y Y Larkin 1998
43
Y Y N Y N Y N Y Y Llibre 2006
44
Y NA Y Y N N Y N Y Modesti 1994
45
Y NA N Y N Y N Y Y Ogedegbe 2008
46
N NA Y Y N N N Y N Ozdemir 2000
47
Y NA Y Y N Y Y Y Y Shimbo 2009
48
Y N Y Y N N Y Y N Stergiou 2000
49
Y Y Y Y N N Y Y N Stergiou 2005
50
Y NA N Y N N N Y Y Trudel 2009
51
Y NA Y Y N N Y Y Y Ungar 2004
52
N NA Y Y Y N N Y Y Zabludowski 1992
53
NA=not applicable.
*Selection=clear selection criteria; measurement times=adequate and clear time period between measurements; replication=sufficient detail to permit replication
of test; blinding=blinding of those performing tests to previous monitoring results; reporting=reporting of uninterpretable test results; reference standard=same
reference standard used across sample; attrition=information on attrition; checking=adequate checking of self monitoring readings; equipment validation=all
measurement kit validated or not.
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RESEARCHTable 3 | Description of methods in studies of ambulatory monitoring compared with clinic monitoring of blood pressure in diagnosis of
hypertension
Mean blood pressure (mm Hg)† No of measurements*
Period of ambulatory
measurement Study Clinic Ambulatory Clinic Ambulatory
102.6 (diastolic) NA 10 or 6 64 Day (06:00-22:00) Brueren 1995
35
156/91 131/89 3 79 (9)§ 22 hours Denolle1995
37
168/101 151/94 3 36 Day (06:00-24:00) Elijovich 1992
38
136.2/84.8 124.1/76.2 3 42 (daytime) Day (08:00-22:00) Flores 2000
39
132/83 131/76 2 24 (daytime) Day (10:00-22:00) Gourlay 1993
40
156.8/99.8 145.2/95.9 5 64 (daytime) Day (07:00-23:00) Hoegholm 1994
41
126/72 120/71 2 46.5 (3.8)§ 24 hours Imai 1996
42
127.8/82.7 132.8/81.9 9 Max 48, mean 45 24 hours Larkin 1998
43
129/85 120/75 2 60 Day (07:00-22:00) Modesti 1994
45
129.3/77.8 129.6/77.9 up to 18 Unclear Day (awake) Ogedegbe 2008
46
NA NA 3 111 24 hours Ozdemir 2000
47
133.5/83 135/83 6 33.4 (11.8)‡ Day (awake) Shimbo 2009
48
143.2/93.0 139.3/91.1 2 102 Day (awake) Stergiou 2000
49
144.7/94.2 140.8/91.3 4 51 Day (awake) Stergiou 2005
50
122.6/76.2 123.9/79.2 3 >20 (c28-32) Working hours Trudel 2009
51
151/93 141/86 4 to 6 60 (day) Day (07:00-22:00) Ungar 2004
52
158.9/90.6 150.5/85.4 3 72 (day) Day (06:00-24:00) Zabludowski 1992
53
NA=not available.
*In Brueren
35 10 or 6 depending on initial office reading (interpreted as baseline for inclusion not test). In Larkin
43 maximum was 48 over 24 h period but mean was
45. In Ogedegbe
46 measurements taken every 15 minutes until 22:00 and every hour between 22:00 and 06:00 next morning. In Ozdemir
47 taken every 10 min
during day (06:00-23:00) and every 45 min through night (23:00-06:00). Stergiou
49 used average (for instance 2nd and 3rd measurement) of fifth and final visit for
clinic measurement; 02:00 and 14:00 for monitoring days 2-6 for home measurement; every 20 min for 24 h on 2 days for ambulatory measurement, so max is
144 measurements but only awake is used, so 102 would be pragmatic average. Stergiou
50 used 3 readings/h over 24 h period (max 72), but only awake readings
used (patients with less than 30 valid readings excluded); pragmatic average 51 readings with 7 hours of sleep assumed. Trudel
51 required at least 20 ambulatory
measurements; 4 taken every hour during working hours. For clinic, Ungar
52 used 2 measurements taken on 2 separate occasions, but on each occasion 3rd
measurement was taken if first 2 differed by more than 5 mm Hg.
†In Brueren
35 for clinic measurement mean blood pressure was 107.7 in 30 and 100.2 in 64. In Flores
39 clinic normotension was 124.7/74.5, white coat hypertension
was 146.1/92.5, hypertension was 140.8/92.0; daytime normotension was 118.6/73.2, hypertension was 138.8/80.2, white coat hypertension was 124.5/77.8. In
Hoegholm
41 n=153 for clinic, 159 for daytime ambulatory. In Zabludowski
53 ambulatory blood pressure: 160/95 for clinic and ambulatory hypertension; 141/77for
clinic hypertension, ambulatory normotension: 163/93 for clinic normotension, ambulatory hypertension; 142/77 for clinic and ambulatory normotension. Clinic
blood pressure: 165/100 for clinic and ambulatory hypertension; 160/94 for clinic hypertension, ambulatory normotension; 151/77 for clinic normotension, ambulatory
hypertension; 151/77 for clinic and ambulatory normotension.
‡Mean (SD).
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RESEARCHTable 4| Description of methods in studies of ambulatory monitoring compared with home monitoring of blood pressure
Mean blood pressure (mm Hg)† No of measurements*
Period of ambulatory
measurement Study Home Ambulatory Home Ambulatory
137.4/82.1 134.8/81.3 18 48 Day (07:00-23:00) Bayo 2006
34
143.1/91.5 148.1/95.0 42 40 Day (08:00-22:00) Den Hond 2003
36
128/87 131/89 29 (2)‡ 79 (9)‡ 22 hours Denolle 1995
37
131.4/80.0 132.8/81.9 56 45 (max 48) 24 hours Larkin 1998
43
136.9/82.1 134.8/81.6 18 48 Day (07:00-23:00) Llibre 2006
44
138.7/89.3 139.3/91.1 20 102 Day (awake) Stergiou 2000
49
*Larkin
43 maximum was 48 over 24 h period but mean was 45. Llibre
44 48 day or 64 all day (unclear which used). Stergiou
49 clinic = average (that is, 2nd and 3rd
measurement) of 5th and final visit; home = 02:00 and 14:00 for monitoring days 2-6; ambulatory=every 20 min for 24 h for 2 days, so max is 144 measurements
but only awake is used, so 102 would be pragmatic average.
†Den Hond
36 home mean also reported as 142.4/91.0 in graph but reading in table accepted as primary result. Llibre
44 daytime: 134.8/81.6; 24 h: 130.4/78.0
‡Mean (SD).
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RESEARCHTable 5| Sensitivity and specificity for ambulatory monitoring compared with clinic monitoring of blood pressure
Likelihood ratio (95% CI)
Specificity % (95%
CI)
Sensitivity % (95%
CI)
Diagnostic thresholds (mm Hg)*
Study Negative Positive Clinic Ambulatory
0.64 (0.39 to 1.04) 1.39 (0.97 to 2.00) 52 (37 to 67) 67 (52 to 80) 95 (diastolic) 91 (diastolic) Brueren 1995
35
0.72 (0.60 to 0.87) 13.42 (1.84 to 97.96) 98 (88 to 100) 29 (17 to 44) 105 (diastolic) 91 (diastolic) Brueren 1995
35
0 0.64 (0.41 to 1.00) 0 (0 to 52) 64 (31 to 89) 140/90 139/87 Denolle1995
37
0.62 (0.17 to 2.21) 1.08 (0.85 to 1.37) 18 (4 to 43) 89 (78 to 96) 140/90 139/88 Elijovich 1992
38
0 2.00 (1.47 to 2.73) 50 (34 to 66) 100 (59 to 100) 140/90 135/85 Flores 2000
39
0.30 (0.14 to 0.65) 5.77 (2.61 to 12.77) 87 (74 to 95) 74 (49 to 91) 150/90 135/85 Gourlay 1993
40
0.56 (0.37 to 0.87) 7.42 (2.25 to 24.47) 94 (82 to 99) 47 (24 to 71) 160/95 135/85 Gourlay 1993
40
0.12 (0.05 to 0.29) 1.65 (1.31 to 2.09) 43 (29 to 57) 95 (89 to 98) 90 (diastolic) 90 (diastolic) Hoegholm 1994
41
0.66 (0.57 to 0.77) 3.36 (2.50 to 4.54) 88 (84 to 90) 42 (33 to 51) 140/90 133/78 Imai 1996
42
0.50 (0.35 to 0.71) 3.76 (2.76 to 5.14) 85 (82 to 87) 58 (42 to 73) 140/90 144/85 Imai 1996
42
0.85 (0.79 to 0.92) 7.74 (3.93 to 15.23) 98 (96 to 99) 17 (11 to 24) 160/95 133/78 Imai 1996
42
0.70 (0.57 to 0.86) 10.43 (5.67 to 19.19) 97 (95 to 98) 33 (19 to 49) 160/95 144/85 Imai 1996
42
0.62 (0.40 to 0.96) 2.31 (1.16 to 4.60) 78 (62 to 89) 52 (31 to 72) 140/90 140/90 Larkin 1998
43
0.58 (0.41 to 0.83) 3.63 (1.38 to 9.53) 86 (68 to 96) 50 (33 to 67) 140/90 135/85 Larkin 1998
43
0.55 (0.37 to 0.82) 3.51 (1.47 to 8.37) 85 (68 to 95) 53 (35 to 71) 140/90 See notes* Larkin 1998
43
0.24 (0.10 to 0.57) 5.01 (3.14 to 7.99) 84 (76 to 90) 80 (56 to 94) 90 (diastolic) See notes* Modesti 1994
45
0.40 (0.31 to 0.52) 3.55 (2.35 to 5.36) 81 (72 to 88) 68 (59 to 76) 140/90 135/85 Ogedegbe 2008
46
0.23 (0.11 to 0.48) 5.91 (3.46 to 10.10) 86 (78 to 93) 80 (61 to 92) 140/90 See notes* Ozdemir 2000
47
0.48 (0.39 to 0.59) 6.12 (3.23 to 11.61) 91 (83 to 96) 57 (48 to 65) 140/90 135/85 Shimbo 2009
48
0.27 (0.15 to 0.48) 1.86 (1.36 to 2.54) 54 (39 to 68) 86 (76 to 92) 140/90 140/90 Stergiou 2000
49
0.30 (0.19 to 0.49) 2.17 (1.37 to 3.42) 63 (44 to 79) 81 (72 to 88) 140/90 135/85 Stergiou 2000
49
0.32 (0.21 to 0.49) 1.56 (1.23 to 1.97) 45 (32 to 58) 86 (80 to 90) 140/90 135/85 Stergiou 2005
50
0.63 (0.59 to 0.67) 21.46 (14.99 to 30.72) 98 (97 to 99) 38 (34 to 42) 140/90 135/85 Trudel 2009
51
0.33 (0.22 to 0.50) 1.35 (1.17 to 1.57) 35 (25 to 45) 89 (84 to 92) 140/90 135/85 Ungar 2004
52
0.40 (0.24 to 0.66) 1.53 (1.23 to 1.90) 47 (36 to 57) 81 (71 to 89) 90 (diastolic) 90 (diastolic) Zabludowski 1992
53
*Modesti
45 used 95% confidence limit of controls (clinic normotension) for day (84 mm Hg) diastolic values. Larkin
43 used 143/91 (day), 139/87 (24 h), 127/79 (night
time). Ozdemir
47 used ambulatory threshold 140/90 (waking) and 120/80 (sleeping) if % of raised readings exceeded 20%.
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RESEARCHTable 6 | Sensitivity and specificity for ambulatory monitoring compared with home monitoring of blood pressure
Likelihood ratio (95% CI)
Specificity % (95% CI) Sensitivity % (95% CI)
Diagnostic thresholds (mm Hg)
Study Negative Positive Home Ambulatory
0.49 (0.32 to 0.73) 1.51 (1.18 to 1.95) 50 (38 to 62) 76 (66 to 83) 135/85 135/85 Bayo 2006
34
0.36 (0.20 to 0.66) 1.33 (1.11 to 1.58) 34 (23 to 46) 88 (80 to 93) 130/80 135/85 Bayo 2006
34
0.17 (0.10 to 0.27) 2.81 (1.45 to 5.45) 68 (43 to 87) 89 (84 to 92) 135/85 135/85 Den Hond 2003
36
0.23 (0.03 to 1.96) 1.52 (0.72 to 3.18) 40 (5 to 85) 91 (59 to 100) 127/83 139/87 Denolle 1995
37
0.43 (0.27 to 0.71) 7.60 (2.45 to 23.58) 92 (79 to 98) 60 (39 to 79) 140/90 140/90 Larkin 1998
43
0.68 (0.52 to 0.88) 2.11 (1.34 to 3.33) 77 (68 to 85) 48 (35 to 61) 140/90 135/85 Llibre 2006
44
0.33 (0.22 to 0.50) 3.11 (1.87 to 5.18) 76 (62 to 87) 75 (64 to 84) 140/90 140/90 Stergiou 2000
49
0.14 (0.08 to 0.27) 2.88 (1.72 to 4.84) 69 (50 to 84) 90 (83 to 95) 135/85 135/85 Stergiou 2000
49
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RESEARCHTable 7| Pooled result for performance of home and clinic measurement of blood pressure in diagnosis of hypertension
Specificity Sensitivity
Relative % (95% CI) Relative (95% CI) % (95% CI)
0.79 (0.40 to 1.55), P=0.49 62.4 (48.0 to 75.0) 1.15 (0.95 to 1.39), P=0.16 85.7 (78.0 to 91.0) Home measurement (n=3)
1.00 (reference) 74.6 (47.9 to 90.4) 1.00 (reference) 74.6 (60.7 to 84.8) Clinic measurement (n=7)
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RESEARCHTable 8| Thresholds for measurement of blood pressure for diagnosis of hypertension in clinic and home measurements
Specificity Sensitivity
Test threshold* Relative (95% CI) % (95% CI) Relative (95% CI) % (95% CI)
Clinic blood pressure test
1.0 (reference) 74.8 (49.8 to 89.8) 1.0 (reference) 74.7 (61.7 to 84.4) 140/90 (n=7)
1.15 (0.71 to 1.88), P=0.57 86.2 (24.8 to 99.2) 0.89 (0.51 to 1.55), P=0.68 66.3 (28.3 to 90.8) 150/90 (n=1)
Home blood pressure test
1.42 (1.20 to 1.68), P<0.001 80.3 (67.9 to 88.7) 0.63 (0.45 to 0.88), P=0.01 52.6 (34.7 to 69.8) 140/90 (n=1)
1.0 (reference) 56.7 (46.4 to 66.4) 1.0 (reference) 83.2 (76.1 to 88.5) 135/85 (n=3)
0.73 (0.57 to 0.93), P=0.01 41.4 (30.1 to 53.5) 1.10 (1.03 to 1.18), P=0.01 91.8 (84.4 to 95.8) 130/80 (n=1)
*n= number of studies.
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RESEARCHTable 9| Probability (%) that test diagnosis is correct (judged by reference standard of ambulatory monitoring) given likelihood ratios (both
positive and negative) and different pre-test probabilities (that is, estimates of population prevalence)
Negative Positive
Prevalence Clinic Home Clinic Home
96 97 25 19 10%
87 90 56 47 30%
75 80 75 67 50%
76 80 61 67 Sensitivity analysis 50%
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RESEARCHFigures
Fig 1 Selection of studies to include in analysis of effectiveness of different types of measuring blood pressure for diagnosis
of hypertension
Fig 2 Paired forest plots of sensitivity and specificity for home v ambulatory and clinic v ambulatory. Multiple analyses were
possible for Bayo et al
34 and Stergiou et al
49 (see tables 5 and 6)
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RESEARCHFig 3 Hierarchical summary receiver operating characteristic plot for clinic v ambulatory measurement of blood pressure
for diagnosis of hypertension
Fig 4 Hierarchical summary receiver operating characteristic plot for home v ambulatory measurement of blood pressure
for diagnosis of hypertension
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